Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
Opportunity Category Explanation:
Funding Instrument Type:
Category of Funding Activity:
Health Income Security and Social Services
Additional Information on Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Department of Health and Human Services National Institutes of Health
Apr 15, 2021
Jul 29, 2021
Last Updated Date:
Apr 15, 2021
Estimated Total Program Funding:
Expected Number of Awards:
The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development of non-hormonal contraceptive product(s) for men and women.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.